[1/28: Free Participation] Sankei Shimbun

The "Regional Healthcare DX Strategy Forum," hosted by Sankei Shimbun and featuring Nihon Keiei as the keynote speaker, goes beyond merely recommending IT adoption.It symbolizes a turning point where "the feasibility of DX adoption will determine the asset value of medical institutions."In the field of medical M&A, a delay in DX is no longer seen as an "opportunity for growth" but as a "management risk" that forces buyers to bear the cost of system renewal after succession.

Especially from the perspective of wide-area medical collaboration and management efficiency, as advocated by Nihon Keiei, digitalization of information is a prerequisite.Facilities clinging to paper medical records and analog operations are increasingly likely to be shunned as "difficult-to-transfer cases" in third-party succession matching, regardless of patient numbers or profits.

For chairpersons and directors struggling with a lack of successors, the strategies discussed at this forum are not just hints for efficiency improvement, but"Polishing to ensure a high-value and secure transfer of their own institution."Reframing DX investment not as a "cost" but as part of an "exit strategy" to advance future business succession favorably is key to protecting sustainable regional healthcare.